Moderna has requested regulatory clearance of its reformulated COVID-19 vaccine, which the company is prepared to start delivering next month with FDA's authorization. The updated product is configured to fight the strain of coronavirus that emerged in 2019 as well as the Omicron BA.4 and BA.5 subvariants now in heavy circulation. Based on favorable results from previous evaluation of a versio...

Read More

Pfizer and BioNTech have applied for FDA authorization of their reformulated COVID-19 booster dose, which targets Omicron subtypes BA.4 and BA.5 as well as the original strain of SARS-CoV-2. Omicron cases are now dominant in the United States, but research has suggested that currently approved vaccines are less effective against the mutation and its subtypes. Human trials of the modified vaccine a...

Read More

Time Magazine - Aug 23, 2022 The Federal Trade Commission recently launched an inquiry into the practices of pharmacy benefit managers, known in the industry as PBMs. PBMs are the hidden middlemen who were supposed to make drug distribution more efficient. Yet over time, they have grown in size and power, and research suggests they have contributed to the rapidly rising costs of presc...

Read More

The Food and Drug Administration (FDA) on Friday cleared Novavax’s COVID-19 vaccine for emergency use in adolescents, paving the way to expand eligibility for the fourth shot available in the United States. The two-dose regimen utilizes protein-based technology previously leveraged in vaccines to combat other viruses, offering an alternative for Americans skeptical of Pfizer and Moderna&r...

Read More

After more than six decades in business, Paul's Pharmacy will close its doors. The business announced the closure Saturday, Aug. 20, as owners Jim and Jamie Bussis begin their retirement. According to the announcement, the pharmacy's last day open was Monday — but closing sales will follow in the coming weeks. Read more.

Read More